Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR. uri icon

Overview

publication date

  • March 3, 2025

Identity

Scopus Document Identifier

  • 85219745124

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-24-5044

PubMed ID

  • 40025966

Additional Document Info

volume

  • 85

issue

  • 5